Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

cardiovascular · Mechanism Report

Does high LDL particle number with optimal LDL-C indicate increased atherosclerotic risk?

When LDL-C is optimal but LDL-P is elevated, an increased LDL particle number indicates higher atherosclerotic cardiovascular risk and predicts events better than LDL-C alone.

SupportedJune 19, 202613 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

When LDL cholesterol is optimal but LDL particle number is elevated, it suggests cholesterol-depleted LDL particles and increased atherogenic exposure; LDL particle number predicts atherosclerotic risk better than LDL cholesterol when they are discordant.

laying out figure…
All 4 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim describes discordance where low LDL-C coexists with elevated LDL-P, implying cholesterol-depleted, small dense LDL particles that raise total atherogenic exposure. Mechanistic evidence frames this by showing these particles penetrate, are retained, and oxidize in the arterial wall more readily, so LDL-P outperforms LDL-C for risk prediction in such cases.

Verified conclusion

Lipid profiles where LDL cholesterol (LDL-C) and LDL particle number (LDL-P) diverge—known as discordance—frequently occur in individuals with metabolic syndrome, insulin resistance, or type 2 diabetes. In these scenarios, LDL-C may appear within an optimal range, yet the patient remains at high risk for atherosclerotic cardiovascular disease (ASCVD).

Clinical and predictive evidence

Large-scale cohort studies and systematic reviews consistently demonstrate that LDL-P is a superior predictor of risk when it diverges from LDL-C.

  • Superior risk stratification: Systematic evaluations involving over 590,000 participants show that LDL-P outperforms LDL-C in approximately 67% of direct comparisons for risk prediction.
  • Risk underestimation: Data from the Multi-Ethnic Study of Atherosclerosis (MESA) and the Framingham Heart Study indicate that individuals with high LDL-P but optimal LDL-C face a 20% to 50% higher risk of cardiovascular events compared to those with concordant low levels.
  • Subclinical atherosclerosis markers: High LDL-P is more strongly associated with increased coronary artery calcium (CAC) prevalence and carotid intima-media thickness (CIMT), even when non-HDL-C levels are low. For a 74-year-old male, these markers are critical, as age already places the individual at a higher baseline risk for plaque accumulation.

Mechanistic explanations

The predictive superiority of LDL-P stems from the physical and chemical changes in LDL particles during states of metabolic dysregulation.

  • Particle composition: When LDL-P is high but LDL-C is low, it indicates that the total pool of LDL is comprised of "cholesterol-depleted" particles. This is often driven by CETP-mediated lipid exchange, where triglycerides replace cholesterol esters within the LDL core. These triglyceride-rich particles are then hydrolyzed by hepatic lipase, resulting in small, dense LDL (sdLDL) variants.
  • Arterial wall penetration: Because sdLDL particles are smaller, they penetrate the subendothelial arterial wall more efficiently than larger, buoyant LDL.
  • Retention and oxidation: Once in the arterial wall, these particles bind more readily to proteoglycans, increasing their retention time. They also have a lower affinity for the LDL receptor, meaning they circulate longer and are more susceptible to oxidative modification, a key step in plaque formation.

Bottom line

LDL-P provides a more accurate assessment of ASCVD risk than LDL-C in discordant cases because it measures the total number of atherogenic vehicles rather than just the volume of cholesterol they carry. For individuals where these metrics diverge, relying solely on LDL-C can lead to a significant underestimation of atherosclerotic risk and missed opportunities for preventive intervention.

References

  1. Abstract 14630: Elevated CETP Activity is Associated With Low, Dysfunctional HDL in High Cardiovascular Risk South Asians — ahajournals.org ↗
  2. Clinical implications of discordance between low-density lipoprotein cholesterol and particle number. — pmc.ncbi.nlm.nih.gov ↗
  3. Small, Dense Low-Density Lipoprotein-Cholesterol and Atherosclerosis: Relationship and Therapeutic Strategies — pmc.ncbi.nlm.nih.gov ↗
  4. Atherosclerosis Development and Progression: The Role of Atherogenic Small, Dense LDL — mdpi.com ↗
  5. Atherosclerosis Development and Progression: The Role of Atherogenic Small, Dense LDL — pmc.ncbi.nlm.nih.gov ↗
  6. Observational study of lipid profile and LDL particle size in patients with metabolic syndrome — pmc.ncbi.nlm.nih.gov ↗
  7. Small Dense Low‐Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study — ahajournals.org ↗
  8. ApoB, LDL-C, and non-HDL-C as markers of cardiovascular risk. — linkinghub.elsevier.com ↗
  9. Association of LDL-cholesterol subfractions with cardiovascular disorders: a systematic review — pmc.ncbi.nlm.nih.gov ↗
  10. Discordance of Low-Density Lipoprotein and High-Density Lipoprotein Cholesterol Particle Versus Cholesterol Concentration for the Prediction of Cardiovascular Disease in Patients With Metabolic Syndrome and Diabetes Mellitus (from the Multi-Ethnic Study of Atherosclerosis [MESA]). — pmc.ncbi.nlm.nih.gov ↗
  11. Discordance between non-HDL-cholesterol and LDL-particle measurements: results from the Multi-Ethnic Study of Atherosclerosis. — pmc.ncbi.nlm.nih.gov ↗
  12. Discordance of Low-Density Lipoprotein (LDL) Cholesterol With Alternative LDL-Related Measures and Future Coronary Events — pmc.ncbi.nlm.nih.gov ↗
  13. Discordance between serum cholesterol concentration and atherogenic lipoprotein particle number in people with metabolic disease: A systematic review — dom-pubs.pericles-prod.literatumonline.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible10 sourcesAre F2-isoprostanes biomarkers of lipid peroxidation and does oxidized LDL contribute to atherosclerosis?→Plausible10 sourcesDo hs-CRP, Lp-PLA2, and myeloperoxidase reflect different cardiovascular risk signals?→